Lang Bu

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Benign Prostatic Hyperplasia

Oxidative Stress

Regulatory T Cells

Top Venues

Science advances

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Bing Gao, Xueji Wu, Lang Bu, Qiwei Jiang, Lei Wang, Haining Liu, Xiaomei Zhang, Yuanzhong Wu, Xiao-Xing Li, Jingting Li, Ying Liang, Lixia Xu, Wei Xie, Jianping Guo
Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis. Science advances 10 (6) (2024)
Bing Gao, Xueji Wu, Lang Bu, Qiwei Jiang, Lei Wang, Haining Liu, Xiaomei Zhang, Yuanzhong Wu, Xiao-Xing Li, Jingting Li, Ying Liang, Lixia Xu, Wei Xie, Jianping Guo
Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis. Science advances 10 (6) (2024)
Bing Gao, Xueji Wu, Lang Bu, Qiwei Jiang, Lei Wang, Haining Liu, Xiaomei Zhang, Yuanzhong Wu, Xiao-Xing Li, Jingting Li, Ying Liang, Lixia Xu, Wei Xie, Jianping Guo
Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis. Science advances 10 (6) (2024)
Bing Gao, Xueji Wu, Lang Bu, Qiwei Jiang, Lei Wang, Haining Liu, Xiaomei Zhang, Yuanzhong Wu, Xiao-Xing Li, Jingting Li, Ying Liang, Lixia Xu, Wei Xie, Jianping Guo
Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis. Science advances 10 (6) (2024)
Zhicheng Sun, Qiwei Jiang, Bing Gao, Xiaomei Zhang, Lang Bu, Lei Wang, Ying Lin, Wei Xie, Jie Li, Jian-Ping Guo
AKT blocks SIK1-mediated repression of STAT3 to promote breast tumorigenesis. Cancer research (2023)